Hysteroscopy Procedures Global Market Report 2024

The hysteroscopy procedures market has grown strongly in recent years. It will grow from $3.75 billion in 2023 to $4.03 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The increase in the historical period can be credited to collaborative efforts with gynecologists, enhancements in diagnostic accuracy, advancements in training and education, expansion in outpatient procedures, and the growing trend towards minimally invasive surgery.

The hysteroscopy procedures market is expected to see strong growth in the next few years. It will grow to $5.29 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The expansion anticipated in the forecast period can be ascribed to persistent research and innovation, heightened awareness campaigns, improved diagnostic accuracy, ongoing training programs, the growth of outpatient procedures, and a growing preference for minimally invasive surgery. Key trends expected in the forecast period involve a rising demand for outpatient procedures, progress in imaging technologies, the incorporation of robotics, emphasis on fertility treatments, and an expanded diagnostic scope.

The anticipated rise in the prevalence of gynecological problems is poised to drive the growth of the hysteroscopy procedure market. Gynecological disorders, encompassing conditions such as uterine fibroids, menstrual disorders, and polycystic ovarian syndrome, disrupt the normal functioning of the female reproductive system. Hysteroscopy procedures play a crucial role in addressing and preventing an increased occurrence of gynecological ailments by diagnosing and treating issues leading to abnormal uterine bleeding, excessive menstrual bleeding, irregular spotting, and postmenopausal bleeding. Notably, a January 2023 article from the National Center for Biotechnology Information highlighted that over 70% of women develop uterine fibroids by the onset of menopause, and clinically noticeable uterine fibroids affect 25% of women in their fertile age. Additionally, a March 2023 article from the World Health Organization reported that endometriosis impacts nearly 10% (190 million) of reproductive-age women and girls globally. Consequently, the surging prevalence of gynecological problems is fueling the expansion of the hysteroscopy procedure market.

The growing demand for minimally invasive procedures is expected to be a significant driver for the hysteroscopy procedures market. Minimally invasive procedures, characterized by small incisions, fine instruments, and advanced imaging technology, are increasingly preferred due to factors such as patient choice, enhanced outcomes, technological advancements, and cost-effectiveness. The surge in demand for minimally invasive procedures has contributed to the growth of hysteroscopy procedures. For example, reports from Intuitive Surgical Inc. in January 2023 indicated that approximately 1,875,000 surgical procedures were performed using the Vinci Surgical System in 2022, reflecting an 18% increase compared to the 1,594,000 procedures conducted in 2021. This underscores the rising preference for minimally invasive procedures, propelling the hysteroscopy procedures market.

Product innovations stand out as a prominent trend in the hysteroscopy procedure market, with companies adopting new technologies to maintain their market standing. In February 2021, VirtaMed AG, a Switzerland-based company specializing in surgical simulators for medical education, introduced a mixed-reality training platform for hysteroscopy and gynecological laparoscopy. The innovative VirtaMed Gynecological laparoscopy simulator combines features of LaparoSTM and GynoSTM hysteroscopy, providing a realistic and proficiency-based healthcare simulation for surgical gynecology training.

Major players in the hysteroscopy procedures market are concentrating on introducing innovative products, such as the Hystero-V single-use hysteroscope, to capitalize on the advantages of single-use technology. The Hystero-V, developed by UroViu, offers several benefits for both physicians and patients, including convenience, safety, cost-effectiveness, and portability. In June 2022, UroViu Corporation launched the Hystero-V single-use hysteroscope, positioning it as a significant advancement in single-use hysteroscopy technology. This device is poised to capture a considerable share of the growing global hysteroscope market.

In February 2021, CooperSurgical Inc., a US-based company specializing in healthcare products for women and families, acquired AEGEA Medical to enhance its product portfolio. The acquisition included AEGEA Medical's FDA-approved Mara Water Vapor Ablation System, a minimally invasive treatment for abnormal uterine bleeding. This strategic move expanded CooperSurgical's reach in the hysteroscopy market, complementing its portfolio of clinic and practice-based women's health products. AEGEA Medical Inc., the acquired company, is dedicated to serving the feminine healthcare industry.

Major companies operating in the hysteroscopy procedures market report are Hologic Inc., CooperSurgical Inc., Stryker Corp., Karl Storz SE & Co. KG, Medtronic plc, Delmont imaging, Johnson & Johnson Services Inc., Olympus Corporation, B. Braun SE, Richard Wolf GmbH, Erbe Elektromedizin GmbH, Boston Scientific Corporation, MedGyn Products Inc., LiNA Medical ApS, LUMINELLE, Meditrina Inc., Maxer Endoscopy GmbH, Medical Devices Business Services Inc., Smith & Nephew plc, Cook Medical LLC, Fujifilm Holdings Corporation, ConMed Corporation, Gyrus ACMI, Silex Medical LLC, EndoChoice Holdings Inc., Endo Optiks Inc., Hysteroscopy Centers of America LLC, Resectoscope Inc., Versicor Inc., ReMed Pharma LLC.

North America was the largest region in the hysteroscopy procedure market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global hysteroscopy procedure market report during the forecast period. The regions covered in the hysteroscopy procedures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hysteroscopy procedures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of products used in hysteroscopy procedures include flexible hysteroscopes, forceps, rigid hysteroscopes, and scissors. Flexible hysteroscopy is considered a secure, efficient, and reliable method for investigating abnormal uterine bleeding. These instruments find applications in various procedures such as hysteroscopy, endometrial ablation, myomectomy, polypectomy, among others, and are utilized by different end-users such as hospitals, clinics, ambulatory surgery centers, and more.

The hysteroscopy procedure market research report provides hysteroscopy procedure market statistics, including hysteroscopy procedure industry global market size, regional shares, competitors with a hysteroscopy procedure market share, detailed hysteroscopy procedure market segments, market trends, and opportunities, and any further data you may need to thrive in the hysteroscopy procedure industry. This hysteroscopy procedure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hysteroscopy procedure market consists of revenues earned by entities by providing diagnostic and operative hysteroscopy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The hysteroscopy procedures market consists of sales of hysteroscopes, hysterosheaths, and hysteroscopic tissue removal systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.